Evidence-based medicine and clinical fluorodeoxyglucose PET/MRI in oncology-Reference-Cited by-同舟云学术

Evidence-based medicine and clinical fluorodeoxyglucose PET/MRI in oncology

Published:2015-11-17 Issue:1 Volume:15 Page:
ISSN:1470-7330
Container-title:Cancer Imaging
language:en
Short-container-title:cancer imaging

Author:

Miles Kenneth,McQueen Liam,Ngai Stanley,Law Phillip

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Radiological and Ultrasound Technology

Link

http://link.springer.com/content/pdf/10.1186/s40644-015-0053-1

Reference26 articles.

1. Osler W. The Quotable Osler Eds Silverman ME, Murray TJ, Bryan CS. (ACP Press, Philadelphia) 2008

2. Technology Brief: PET-MRI integrated hybrid scanners. Health Policy Advisory Committee on Technology (State of Queensland (Queensland Health), Brisbane) 2012.

3. Hybrid PET/MR systems for whole-body diagnostic imaging. (NIHR Horizon Scanning Centre, University of Birmingham) 2012.

4. Brix G, Lechel U, Glatting G, Ziegler SI, Münzing W, Müller SP, et al. Radiation exposure of patients undergoing whole-body dual-modality 18 F-FDG PET/CT examinations. J Nucl Med. 2005;46:608–13.

5. Gaertner FC, Furst S, Schwaiger M. PET/MR: A paradigm shift. Cancer Imaging. 2013;13:36–52.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults;Gut;2024-04-16

2. Breast Imaging Physics in Mammography (Part II);Diagnostics;2023-12-01

3. Diagnostic potential of [18F]FDG PET/MRI in non-small cell lung cancer lymph node metastasis: a meta-analysis;Japanese Journal of Radiology;2023-08-11

4. Diagnostic performance of whole-body [18F]FDG PET/MR in cancer M staging: A systematic review and meta-analysis;European Radiology;2023-08-03

5. Melanoma;Oncologic Imaging : a Multidisciplinary Approach;2023